Abstract
Haematopoietic stem cell (HSC) homeostasis is tightly controlled by growth factors, signalling molecules and transcription factors. Definitive HSCs derived during embryogenesis in the aorta–gonad–mesonephros region subsequently colonize fetal and adult haematopoietic organs1,2. To identify new modulators of HSC formation and homeostasis, a panel of biologically active compounds was screened for effects on stem cell induction in the zebrafish aorta–gonad–mesonephros region. Here, we show that chemicals that enhance prostaglandin (PG) E2 synthesis increased HSC numbers, and those that block prostaglandin synthesis decreased stem cell numbers. The cyclooxygenases responsible for PGE2 synthesis were required for HSC formation. A stable derivative of PGE2 improved kidney marrow recovery following irradiation injury in the adult zebrafish. In murine embryonic stem cell differentiation assays, PGE2 caused amplification of multipotent progenitors. Furthermore, ex vivo exposure to stabilized PGE2 enhanced spleen colony forming units at day 12 post transplant and increased the frequency of long-term repopulating HSCs present in murine bone marrow after limiting dilution competitive transplantation. The conserved role for PGE2 in the regulation of vertebrate HSC homeostasis indicates that modulation of the prostaglandin pathway may facilitate expansion of HSC number for therapeutic purposes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dzierzak, E. The emergence of definitive hematopoietic stem cells in the mammal. Curr. Opin. Hematol. 12, 197–202 (2005)
Galloway, J. L. & Zon, L. I. Ontogeny of hematopoiesis: examining the emergence of hematopoietic cells in the vertebrate embryo. Curr. Top. Dev. Biol. 53, 139–158 (2003)
North, T. E. et al. Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity 16, 661–672 (2002)
Mukouyama, Y. et al. Hematopoietic cells in cultures of the murine embryonic aorta-gonad-mesonephros region are induced by c-Myb. Curr. Biol. 9, 833–836 (1999)
Kalev-Zylinska, M. L. et al. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1–CBF2T1 transgene advances a model for studies of leukemogenesis. Development 129, 2015–2030 (2002)
Grosser, T., Yusuff, S., Cheskis, E., Pack, M. A. & FitzGerald, G. A. Developmental expression of functional cyclooxygenases in zebrafish. Proc. Natl Acad. Sci. USA 99, 8418–8423 (2002)
Cha, Y. I., Kim, S. H., Solnica-Krezel, L. & Dubois, R. N. Cyclooxygenase-1 signaling is required for vascular tube formation during development. Dev. Biol. 282, 274–283 (2005)
Cha, Y. I. et al. Cyclooxygenase-1-derived PGE2 promotes cell motility via the G-protein-coupled EP4 receptor during vertebrate gastrulation. Genes Dev. 20, 77–86 (2006)
Burns, C. E., Traver, D., Mayhall, E., Shepard, J. L. & Zon, L. I. Hematopoietic stem cell fate is established by the Notch-Runx pathway. Genes Dev. 19, 2331–2342 (2005)
Nakano, T., Kodama, H. & Honjo, T. In vitro development of primitive and definitive erythrocytes from different precursors. Science 272, 722–724 (1996)
Ivanova, N. B. et al. A stem cell molecular signature. Science 298, 601–604 (2002)
Akashi, K. et al. Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood 101, 383–389 (2003)
Venezia, T. A. et al. Molecular signatures of proliferation and quiescence in hematopoietic stem cells. PLoS Biol. 2, e301 (2004)
Zhang, C. C. & Lodish, H. F. Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells. Blood 103, 2513–2521 (2004)
Boer, A. K., Drayer, A. L., Rui, H. & Vellenga, E. Prostaglandin-E2 enhances EPO-mediated STAT5 transcriptional activity by serine phosphorylation of CREB. Blood 100, 467–473 (2002)
Rocca, B. et al. Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. Proc. Natl Acad. Sci. USA 99, 7634–7639 (2002)
Feher, I. & Gidali, J. Prostaglandin E2 as stimulator of haemopoietic stem cell proliferation. Nature 247, 550–551 (1974)
Langenbach, R., Loftin, C., Lee, C. & Tiano, H. Cyclooxygenase knockout mice: models for elucidating isoform-specific functions. Biochem. Pharmacol. 58, 1237–1246 (1999)
Langenbach, R. et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83, 483–492 (1995)
Lorenz, M. et al. Cyclooxygenase-2 is essential for normal recovery from 5-fluorouracil-induced myelotoxicity in mice. Exp. Hematol. 27, 1494–1502 (1999)
Cayeux, S. J., Beverley, P. C., Schulz, R. & Dorken, B. Elevated plasma prostaglandin E2 levels found in 14 patients undergoing autologous bone marrow or stem cell transplantation. Bone Marrow Transplant. 12, 603–608 (1993)
Talosi, G. et al. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects. J. Perinat. Med. 32, 368–374 (2004)
Thanopoulos, B. D., Andreou, A. & Frimas, C. Prostaglandin E2 administration in infants with ductus-dependent cyanotic congenital heart disease. Eur. J. Pediatr. 146, 279–282 (1987)
Hertelendy, F., Woods, R. & Jaffe, B. M. Prostaglandin E levels in peripheral blood during labor. Prostaglandins 3, 223–227 (1973)
Zhu, H. et al. Regulation of the lmo2 promoter during hematopoietic and vascular development in zebrafish. Dev. Biol. 281, 256–269 (2005)
Weber, G. J. et al. Mutant-specific gene programs in the zebrafish. Blood 106, 521–530 (2005)
Pini, B. et al. Prostaglandin E synthases in zebrafish. Arterioscler. Thromb. Vasc. Biol. 25, 315–320 (2005)
Traver, D. et al. Effects of lethal irradiation in zebrafish and rescue by hematopoietic cell transplantation. Blood 104, 1298–1305 (2004)
Kyba, M. et al. Enhanced hematopoietic differentiation of embryonic stem cells conditionally expressing Stat5. Proc. Natl Acad. Sci. USA 100 (Suppl 1). 11904–11910 (2003)
Wang, Y., Yates, F., Naveiras, O., Ernst, P. & Daley, G. Q. Embryonic stem cell-derived hematopoietic stem cells. Proc. Natl Acad. Sci. USA 102, 19081–19086 (2005)
Acknowledgements
We thank the Institute of Chemical and Cellular Biology at Harvard Medical School for access to the chemical libraries used in the screen. We thank: A. Flint, E. Mayhall and C.E. Burns for technical assistance and advice on the kidney marrow analysis; C. Thisse and B. Thisse for information and plasmids for PTGER2; and A. Meyers and J. Ojeda for technical help with the zebrafish chemical screen. This work was supported by grants from the National Institutes of Health (T.E.N., W.G., G.Q.D., S.H.O., G.A.F. and L.I.Z), the American Cancer Socitey (T.E.N.), the American Gastroenterological Association (W.G.), the Leukemia and Lymphoma Society (C.R.W.), the American Heart Association (T.G.) and the Dr. Mildred Scheel Foundation for Cancer Research (C.L.). S.H.O. and L.I.Z. are Howard Hughes Medical Institute investigators.
Author Contributions T.E.N. and K.R.K. conducted the chemical screen. T.E.N., W.G. and A.M.L. performed the zebrafish prostaglandin studies. T.E.N. and C.R.W. conducted the murine experiments. G.J.W. completed the microarray analysis. T.E.N., W.G. and T.V.B. performed 5-FU treatment. T.G. provided cox1 and cox2 probes and completed the mass spectroscopy analysis. C.L. and I.H.J. performed the embryonic stem cell assays. T.E.N., W.G. and L.I.Z. wrote the manuscript. All authors discussed results and commented on the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.
Supplementary information
Supplementary Information
This file contains Supplementary Figures 1-5 with Legends and Supplementary Tables 1-10. (PDF 2101 kb)
Rights and permissions
About this article
Cite this article
North, T., Goessling, W., Walkley, C. et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447, 1007–1011 (2007). https://doi.org/10.1038/nature05883
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nature05883
This article is cited by
-
Pro- and anti-inflammatory bioactive lipids imbalance contributes to the pathobiology of autoimmune diseases
European Journal of Clinical Nutrition (2023)
-
Nod1-dependent NF-kB activation initiates hematopoietic stem cell specification in response to small Rho GTPases
Nature Communications (2023)
-
Activation of lineage competence in hemogenic endothelium precedes the formation of hematopoietic stem cell heterogeneity
Cell Research (2023)
-
Identification of side effects of COVID-19 drug candidates on embryogenesis using an integrated zebrafish screening platform
Scientific Reports (2023)
-
Nuclear Tubulin Enhances CXCR4 Transcription and Promotes Chemotaxis Through TCF12 Transcription Factor in human Hematopoietic Stem Cells
Stem Cell Reviews and Reports (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.